PYC Therapeutics Limited (PYCXF)
OTCMKTS · Delayed Price · Currency is USD
1.260
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST
PYC Therapeutics Market Cap
PYC Therapeutics has a market cap or net worth of $704.5 million as of February 12, 2026. Its market cap has increased by 127.93% in one year.
Market Cap
704.50M
Enterprise Value
596.60M
Revenue
15.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.26
Market Cap Chart
Since March 30, 2005, PYC Therapeutics's market cap has increased from 21.64M to 704.50M, an increase of 3,155.23%. That is a compound annual growth rate of 18.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 704.50M | 9.42% |
| Dec 31, 2025 | 643.87M | 68.92% |
| Dec 31, 2024 | 381.16M | 36.18% |
| Dec 29, 2023 | 279.90M | 87.63% |
| Dec 30, 2022 | 149.18M | -52.22% |
| Dec 31, 2021 | 312.24M | -13.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 413.38M |
| CytoDyn | 304.50M |
| Silence Therapeutics | 213.03M |
| Vaxart | 145.24M |
| HST Global | 139.70M |
| BioStem Technologies | 113.23M |
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |